Paper Details

  1. Home
  2. Paper Details

A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.

Author: DeFeo-FrauliniTia, EllenbogenAaron, FreedMartin I, GrossetDonald G, HampsonNeil B, HauserRobert A, KieburtzKarl D, LeWittPeter A, LeinonenMika, Saint-HilaireMarie-Helene, StocchiFabrizio

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

CVT-301, a levodopa inhalation powder, is being studied as a potential treatment for Parkinson's disease (PD) patients experiencing motor fluctuations.
Paper Details　
Original Abstract of the Article :
Although levodopa is the most effective oral PD therapy, many patients experience motor fluctuations, including sudden loss of dose effect and delayed benefit. CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action. The objective of this study was to evaluate CVT-301 se...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/mds.26611

データ提供：米国国立医学図書館（NLM）

Inhaled Levodopa for Parkinson's Disease: A New Path for Managing Motor Fluctuations

Parkinson's disease (PD) is a chronic neurodegenerative disorder that affects movement and coordination. This study explores the potential of inhaled levodopa, a novel drug delivery method, for managing motor fluctuations, a common challenge for patients with PD. The researchers evaluated the effectiveness and safety of inhaled levodopa for alleviating 'OFF' episodes, periods of reduced medication effect.

Inhaled Levodopa: A New Route for Parkinson's Disease Management

The study's findings suggest that inhaled levodopa may offer a promising alternative for managing motor fluctuations in PD. The researchers observed a rapid onset of action for inhaled levodopa, potentially offering a more effective way to address 'OFF' episodes. It's like discovering a hidden path in the desert, leading to a source of relief for those who have been struggling with debilitating fluctuations in movement.

A New Approach for Managing Parkinson's Disease

The study's findings highlight the potential of inhaled levodopa as a valuable addition to the treatment armamentarium for PD. This novel approach could offer a more effective and convenient way to manage motor fluctuations, improving quality of life for patients. It's like finding a new oasis in the desert of Parkinson's disease, offering a source of comfort and relief for those who have been seeking a better way to manage their condition.

Dr.Camel's Conclusion

This study explores the promise of inhaled levodopa for managing motor fluctuations in Parkinson's disease. This novel approach, like a refreshing breeze in the desert, could offer a new source of relief and improve the quality of life for patients with this debilitating condition.

Date :
  1. Date Completed 2018-01-01
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

27090868

DOI: Digital Object Identifier

10.1002/mds.26611

Related Literature

Article Analysis
・Effects of levodopa oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.